Are Vancomycin Non-Susceptible Clostridioides Difficile Strains Emerging?

Overview

Journal Clin Infect Dis

Publisher Oxford University Press

Specialty Infectious Diseases

Date 2022 Jul 12

PMID 35818797

Authors

Joseph D Lutgring

Susannah L McKay

Amy S Gargis

Alison L Halpin

L Clifford McDonald

Affiliations

Soon will be listed here.

Citing Articles

Clostridioides difficile infections caused by hypervirulent strains: a single-centre real-life study.

Tiecco G, De Francesco M, Lenzi A, Pellizzeri S, Rossini F, Sollima A Eur J Clin Microbiol Infect Dis. 2024; 44(1):99-107.

PMID: 39527170 DOI: 10.1007/s10096-024-04982-w.

Genetic determinants of resistance to antimicrobial therapeutics are rare in publicly available Clostridioides difficile genome sequences.

Kolte B, Nubel U J Antimicrob Chemother. 2024; 79(6):1320-1328.

PMID: 38598696 PMC: 11144481. DOI: 10.1093/jac/dkae101.

Infection: Diagnosis and Treatment Challenges.

Markantonis J, Fallon J, Madan R, Alam M Pathogens. 2024; 13(2).

PMID: 38392856 PMC: 10891949. DOI: 10.3390/pathogens13020118.

Inhibition of selenoprotein synthesis is not the mechanism by which auranofin inhibits growth of Clostridioides difficile.

Johnstone M, Holman M, Self W Sci Rep. 2023; 13(1):14733.

PMID: 37679389 PMC: 10484987. DOI: 10.1038/s41598-023-36796-9.

Reference Susceptibility Testing and Genomic Surveillance of Clostridioides difficile, United States, 2012-17.

Gargis A, Karlsson M, Paulick A, Anderson K, Adamczyk M, Vlachos N Clin Infect Dis. 2022; 76(5):890-896.

PMID: 36208202 PMC: 10839785. DOI: 10.1093/cid/ciac817.

References

Karlowsky J, Adam H, Baxter M, Dutka C, Nichol K, Laing N . Antimicrobial susceptibility of Clostridioides difficile isolated from diarrhoeal stool specimens of Canadian patients: summary of results from the Canadian Clostridioides difficile (CAN-DIFF) surveillance study from 2013 to 2017. J Antimicrob Chemother. 2020; 75(7):1824-1832. DOI: 10.1093/jac/dkaa118. View

Baktash A, Corver J, Harmanus C, Smits W, Fawley W, Wilcox M . Comparison of Whole-Genome Sequence-Based Methods and PCR Ribotyping for Subtyping of Clostridioides difficile. J Clin Microbiol. 2021; 60(2):e0173721. PMC: 8849210. DOI: 10.1128/JCM.01737-21. View

Johnson S, Lavergne V, Skinner A, Gonzales-Luna A, Garey K, Kelly C . Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults. Clin Infect Dis. 2021; 73(5):755-757. DOI: 10.1093/cid/ciab718. View

Darkoh C, Keita K, Odo C, Oyaro M, Brown E, Arias C . Emergence of Clinical Clostridioides difficile Isolates With Decreased Susceptibility to Vancomycin. Clin Infect Dis. 2022; 74(1):120-126. PMC: 8752249. DOI: 10.1093/cid/ciaa912. View

Humphries R, Bobenchik A, Hindler J, Schuetz A . Overview of Changes to the Clinical and Laboratory Standards Institute M100, 31st Edition. J Clin Microbiol. 2021; 59(12):e0021321. PMC: 8601225. DOI: 10.1128/JCM.00213-21. View